The aim of the present prospective study was to substantiate possible side effects of short-term oral acitretin therapy (1 mg/kg/day) on peripheral nerve function of 13 patients with severe keratinization disorders. Clinical neurological examination before and 1 and 3 months after onset of treatment was unremarkable in all patients; however, a significant alteration of one or more neurophysiological, predominantly sensory, parameters was demonstrated in 3 out of 13 patients (23%) after 1 month and in 9 out of 13 (69%) after 3 months of oral acitretin therapy. These findings indicate that oral acitretin might be capable of causing a dysfunction of predominantly sensory nerve fibres in some individuals. Although in the investigated patients this dysfunction remained subclinical, it seems reasonable to suggest that neurological and neurophysiological evaluation of peripheral nerves should be added to the list of investigations that are routinely performed in patients receiving oral acitretin.

Download full-text PDF

Source
http://dx.doi.org/10.1080/000155501317208372DOI Listing

Publication Analysis

Top Keywords

oral acitretin
20
acitretin therapy
12
effects short-term
8
short-term oral
8
peripheral nerve
8
nerve function
8
neurological neurophysiological
8
oral
5
acitretin
5
patients
5

Similar Publications

Article Synopsis
  • Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition with unclear causes, making treatment challenging.
  • This study reviews the effectiveness and safety of antibiotics, hormonal treatments, and oral retinoids in managing HS.
  • Results showed that while antibiotics were effective, hormonal therapies and oral retinoids also showed potential for symptom relief, highlighting the need for customized treatment plans for patients.
View Article and Find Full Text PDF

We report a case of a Filipino child who presented with yellowish hyperkeratotic plaques on the palms and soles with palmar transgredient extension to the wrists, a yellowish hyperkeratotic plaque over the coccygeal area, and brownish-black hyperkeratotic perianal plaques. Patient had delayed physical development and short stature, but no intellectual disability. Histopathologic examination showed palmoplantar keratoderma.

View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed tissue samples from 11 patients with difficult-to-treat CHE, finding increased levels of key cytokines (IL-4, TNF-α, IFN-γ) compared to unaffected skin.
  • * Tofacitinib was administered to 15 patients, showing promising results with a mean improvement in eczema severity after 4 weeks, although some experienced side effects and relapses after stopping treatment.
View Article and Find Full Text PDF

New and emerging oral therapies for psoriasis.

Drugs Context

August 2024

Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.

Article Synopsis
  • - Psoriasis is a chronic skin disease affecting 2-3% of people globally, with traditional treatments like methotrexate having limited effectiveness and potential side effects requiring ongoing monitoring.
  • - New biologic drugs provide better safety and efficacy but are costly and require injections, leading to increased interest in developing targeted oral therapies.
  • - Promising small molecules, such as phosphodiesterase 4 and TYK2 inhibitors, along with other oral agents targeting specific pathways, are being researched to combine the effectiveness of biologics with the ease of oral administration.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!